Vascular Permeability Factor/vascular Endothelial Growth Factor And The Significance Of Microvascular Hyperpermeability In Angiogenesis.
H. Dvorak, J. Nagy, D. Feng, L. F. Brown, A. Dvorak
Published 1999 · Biology, Medicine
Download PDFAnalyze on Scholarcy
This Chapter has reviewed the literature concerning VPF/VEGF as a potent vascular permeabilizing cytokine. In accord with this important role, microvessels have been found to be hyperpermeable to plasma proteins and other circulating macromolecules at sites where VPF/VEGF and its receptors are overexpressed, i.e., in tumors, healing wounds, retinopathies, many important inflammatory conditions and in certain physiological processes, such as ovulation and corpus luteum formation. Moreover, microvascular hyperpermeability to plasma proteins was shown to have an important consequence: the laying down of a fibrin-rich extracellular matrix. This provisional matrix, in turn, favors and supports the ingrowth of fibroblasts and endothelial cells which, together, transform the provisional matrix into the mature stroma characteristic of tumors and healed wounds. Finally, we have considered the pathways by which these and other circulating macromolecules cross the endothelium of normal and VPF/VEGF-permeabilized microvessels. These pathways include VVOs and trans-endothelial openings that have been variously interpreted as inter-endothelial cell gaps or trans-endothelial cell pores. At least some trans-endothelial cell pores may arise from VVOs. In conclusion, these data provide new insights into the mechanisms of angiogenesis and stroma formation, insights which are potentially applicable to a wide variety of disease states and which may lead to identification of new targets for therapeutic intervention.
This paper references
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels
H. Dvorak (1991)
Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development.
B. R. Kamat (1995)
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
J. Li (1996)
Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas.
L. F. Brown (1988)
Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study.
N. Chow (1997)
Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.
H. Dvorak (1979)
Molecular and biological properties of the vascular endothelial growth factor family of proteins.
N. Ferrara (1992)
Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining.
J. Nagy (1995)
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L. Aiello (1994)
Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary.
N. Ravindranath (1992)
Openings in frog microvascular endothelium induced by high intravascular pressures.
C. R. Neal (1996)
Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.
K. Cullinan-Bove (1993)
Oxygen tension regulates the expression of angiogenesis factor by macrophages.
D. Knighton (1983)
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
K. T. Yeo (1993)
Cell signaling, permeability, and microvasculatory changes during antral follicle development in mammals.
R. Moor (1986)
Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.
L. Morbidelli (1996)
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
D. Senger (1983)
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
H. Dvorak (1986)
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors.
E. Pick (1970)
Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor.
M. Dougher-Vermazen (1994)
Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.
L. F. Brown (1988)
Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
K. Lin (1994)
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
H. Dvorak (1992)
Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.
T. Murata (1995)
Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
J. Pe’er (1995)
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
H. Dvorak (1995)
STUDIES ON INFLAMMATION I. The Effect of Histamine and Serotonin on Vascular Permeability: An Electron Microscopic Study
G. Majno (1961)
Nitric oxide modulates microvascular permeability.
P. Kubes (1992)
Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.
A. Minchenko (1994)
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Yasuhiro Matsumura (1988)
The passage of colloidal particles across the dermal capillary wall under the influence of histamine.
J. Alksne (1959)
Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.
M. Detmar (1997)
Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels.
D. Bates (1996)
Endothelial Cell Biology in Health and Disease
N. Simionescu (1988)
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
K. Plate (1992)
Capillary permeability and how it may change.
C. Michel (1988)
Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
D. Feng (1996)
Deoxygenation-induced cation fluxes in sickle cells. IV. Modulation by external calcium.
C. Joiner (1995)
Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains
D. Guo (1995)
The formation of lymph in the ovary
B. Morris (1966)
The endothelial vesicle system in cryofixed frog mesenteric capillaries analysed by ultrathin serial sectioning.
J. Frøkjaer-Jensen (1991)
Effects of a TV Drama Series upon Public Impressions about Psychiatrists
J. Sancho-Aldridge (1994)
Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy.
A. Hirata (1995)
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
E. Pierce (1995)
THE ULTRASTRUCTURAL BASIS OF CAPILLARY PERMEABILITY STUDIED WITH PEROXIDASE AS A TRACER
M. Karnovsky (1967)
Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
K. Weindel (1994)
Vascular endothelial growth factor is expressed in rat corpus luteum.
H. Phillips (1990)
Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy
A. P. Adamis (1994)
Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.
M. Simon (1995)
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis
M. Detmar (1994)
Microvascular permeability of normal and neoplastic tissues.
L. E. Gerlowski (1986)
ROLE OF THE CLOTTING SYSTEM IN CELL-MEDIATED HYPERSENSITIVITY
R. Colvin (1973)
Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.
S. Kohn (1992)
Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.
D. Senger (1990)
Permeability of ovarian follicles and capillaries in mice.
A. Payer (1975)
Vascular leakage through intraendothelial channels induced by cholera toxin in the skin of guinea pigs.
P. H. Hashimoto (1974)
Healing of partial thickness porcine skin wounds in a liquid environment.
K. Breuing (1992)
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
L. F. Brown (1993)
Cellular aspects of transcapillary exchange.
N. Simionescu (1983)
Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
H. Yoshiji (1997)
The Microvascular Endothelium Revisited
G. Palade (1988)
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
S. Nakano (1996)
Quantitative study of vascularity in Walker carcinoma 256.
C. Song (1971)
Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas.
H. Dvorak (1984)
Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
M. Ramírez (1995)
Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.
J. Nagy (1995)
On the Mechanism of Vascular Leakage Caused by Histamine‐Type Mediators: A Microscopic Study In Vivo
G. Majno (1967)
131I‐labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials
I. Spar (1967)
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.
B. Berse (1992)
The vesiculo‐vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation
A. Dvorak (1996)
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
F. Yuan (1996)
Tumor blood circulation : angiogenesis, vascular morphology, and blood flow of experimental and human tumors
H. Peterson (1979)
Nagy JA, Herzberg KT, Dvorak JM, Dvorak HFPathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res 53(11): 2631-2643
J. Nagy (1993)
Vascular-extravascular exchange of II31 plasma proteins in the rat.
W. Dewey (1959)
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
M. Jeltsch (1997)
Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
Y. Watanabe (1997)
Transport of macromolecules across microvascular walls: the two-pore theory.
B. Rippe (1994)
Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
J. Nagy (1993)
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.
K. Houck (1991)
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells
Y. Watanabe (1997)
Transcellular gaps in microvascular walls of frog and rat when permeability is increased by perfusion with the ionophore A23187.
C. R. Neal (1995)
Nitric oxide affects microvascular permeability in the intact and inflamed vasculature.
P. Kubes (1995)
Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade.
Y. Yuan (1993)
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
B. Olffson (1996)
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
B. Terman (1992)
Identification of a new endothelial cell growth factor receptor tyrosine kinase.
B. Terman (1991)
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
G. Abu-Jawdeh (1996)
Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.
L. F. Brown (1993)
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
J. Waltenberger (1994)
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.
T. Quinn (1993)
INTESTINAL CAPILLARIES: I. Permeability to Peroxidase and Ferritin
F. Clementi (1969)
Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy.
H. Dvorak (1990)
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
C. de Vries (1992)
Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.
S. O'Connor (1984)
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
T. Murohara (1998)
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
L. F. Brown (1995)
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
J. W. Miller (1994)
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
B. Olofsson (1996)
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.
H. Dvorak (1988)
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.
G. Breier (1992)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
F. Yuan (1995)
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.
E. Hatva (1995)
Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.
R. van der Zee (1997)
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.
W. Roberts (1995)
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.
W. T. Monacci (1993)
Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
David D. Ku (1993)
Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.
H. Dvorak (1991)
Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.
R. Colvin (1975)
Regulation of extravascular coagulation by microvascular permeability.
H. Dvorak (1985)
STUDIES ON INFLAMMATION
G. Majno (1961)
ENDOTHELIAL CONTRACTION INDUCED BY HISTAMINE-TYPE MEDIATORS
G. Majno (1969)
Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme.
L. F. Brown (1995)
Induction of Vascular Endothelial Growth Factor Gene Expression by Interleukin-1 in Rat Aortic Smooth Muscle Cells (*)
J. Li (1995)
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
L. F. Brown (1992)
Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
A. Koch (1994)
Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
W. Roberts (1993)
Modulation by nitric oxide of platelet‐activating factor‐induced albumin extravasation in the conscious rat
J. Filep (1993)
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
M. Ziche (1997)
Vascular permeability factor, an endothelial cell mitogen related to PDGF.
P. J. Keck (1989)
Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.
H. Dvorak (1979)
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
L. Seetharam (1995)
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
D. Senger (1986)
The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
K. Kim (1992)
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.
S. Banai (1994)
Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.
D. Gospodarowicz (1989)
Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen.
L. F. Brown (1995)
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.
G. Conn (1990)
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
D. Shweiki (1993)
Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores.
D. Feng (1997)
Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.
A. J. Guidi (1995)
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
J. Park (1993)
Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.
K. Peters (1993)
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
B. Millauer (1993)
[An ultrastructural study of capillary permeability of rabbit ovarian follicles during ovulation using carbon tracer (author's transl)].
Y. Okuda (1980)
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
M. Clauss (1990)
Transport pathways in capillaries--in search of pores.
M. Bundgaard (1980)
Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
J. Nagy (1995)
Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.
J. Nagy (1989)
Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.
T. Brock (1991)
Vascular endothelial growth factor is a secreted angiogenic mitogen.
D. W. Leung (1989)
Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
L. F. Brown (1995)
A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.
V. Joukov (1996)
Parvalbumin relaxes frog skeletal muscle when sarcoplasmic reticulum Ca(2+)-ATPase is inhibited.
Y. Jiang (1996)
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue
R. Fava (1994)
Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart.
E. Hashimoto (1994)
Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.
M. Goldberg (1994)
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
D. Connolly (1989)
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.
G. Conn (1990)
The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction.
I. Joris (1987)
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. 1989.
N. Ferrara (1989)
The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat
N. Boughton-Smith (1993)
Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.
A. Miles (1952)
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
T. Alon (1995)
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.
Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart.
A. Ladoux (1993)
Endothelial gaps: time course of formation and closure in inflamed venules of rats.
P. Baluk (1997)
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
Y. Tsurumi (1997)
Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.
D. Fukumura (1997)
Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
L. F. Brown (1997)
Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
L. F. Brown (1996)
Fibrin deposition in autochthonous Syrian hamster pancreatic adenocarcinomas induced by the chemical carcinogen N-nitroso-bis(2-oxopropyl)amine.
L. F. Brown (1987)
Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
K. Claffey (1996)
A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.
W. Matthews (1991)
Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor
H. Maeda (1994)
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
D. Shweiki (1992)
Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
T. Sioussat (1993)
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.
A. P. Adamis (1993)
This paper is referenced by
Regulation und Bedeutung von angiogenen, anti-angiogenen und lymphangiogenen Faktoren während verschiedener Stadien der Ovarfunktion beim Rind
Ludwig-Maximilians-Universitaet Muenchen (2009)
Vascular endothelial growth factor mediates the estrogen-induced breakdown of tight junctions between and increase in proliferation of microvessel endothelial cells in the baboon endometrium.
G. Aberdeen (2008)
Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd‐DTPA and USPIO‐enhanced imaging
J. Boult (2016)
Développement d'une thérapie anti-angiogène et anti-tumorale utilisant les propriétés de la protéine à doigts de zinc TIS11b
S. Planel (2008)
Angiogenesis in cancer and other diseases
P. Carmeliet (2000)
Ultrastructure of Human Mast Cells
A. Dvorak (2002)
Lymphatic Vessel Density and Lymphangiogenesis in Human Oral Squamous Cell Carcinoma
Shunichi Yoshida (2006)
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
S. Lee (2007)
Therapeutic Angiogenesis for Treatment of Peripheral Vascular Disease
N. M. Idris (2004)
Improved free vascular graft survival in an irradiated surgical site following topical application of rVEGF.
S. Schultze–Mosgau (2003)
CHAPTER 18 – Ovarian Angiogenesis
E. Geva (2004)
The role of neuropilin in vascular and tumor biology.
M. Klagsbrun (2002)
Expansion of microvascular bed and increased solute flux in human Basal cell carcinoma in vivo, measured by fluorescein video angiography.
A. W. Stanton (2003)
Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
S. Mudaliar (2003)
Tyrosine Residues 951 and 1059 of Vascular Endothelial Growth Factor Receptor-2 (KDR) Are Essential for Vascular Permeability Factor/Vascular Endothelial Growth Factor-induced Endothelium Migration and Proliferation, Respectively*
H. Zeng (2001)
Cell-cell interactions in vascular development.
D. Darland (2001)
Vascular endothelial growth factor in developing ovine lung: endogenous expression and effec ts of exogenous administration on respiratory syncytial virus infection
Alicia K. Olivier (2010)
Feline Infectious Peritonitis
A. Kipar (2014)
Visualizing vascular permeability and lymphatic drainage using labeled serum albumin
K. Vandoorne (2010)
Effects of an anabolic steroid (Durateston) on testicular angiogenesis in peripubertal stallions.
A. Teubner (2015)
Genetically engineered human muscle transplant enhances murine host neovascularization and myogenesis
L. Perry (2018)
Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins.
D. Herr (2013)
VEGF-A and VEGF-F evoke distinct changes in vascular ultrastructure.
Y. Matsunaga (2009)
Anti-Vascular Endothelial Growth Factor Treatment Augments Tumor Radiation Response under Normoxic or Hypoxic Conditions 1
Chang-geol Lee (2000)
Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy
M. Leggas (2008)
Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP
T. Takano (2011)
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
R. Kumar (2019)
The Beneficial Effect of Melatonin in Brain Endothelial Cells against Oxygen-Glucose Deprivation Followed by Reperfusion-Induced Injury
Juhyun Song (2014)
Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment.
Y. Rolland (2006)
Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.
E. Tassi (2006)
VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations.
J. Nagy (2002)
Promotion Effect of Apo-9'-fucoxanthinone from Sargassum muticum on Hair Growth via the Activation of Wnt/β-Catenin and VEGF-R2.
J. Kang (2016)See more